Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Richard F Ambinder
2017
Open Access

Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity

Martin, A. R., Pollack, R. A., Capoferri, A., Ambinder, R. F., Durand, C. & Siliciano, R. F., Feb 1 2017, In : Journal of Clinical Investigation. 127, 2, p. 651-656 6 p.

Research output: Contribution to journalArticle

Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: Implications for immunotherapy

Duffield, A. S., Ascierto, M. L., Anders, R. A., Taube, J. M., Meeker, A. K., Chen, S., McMiller, T. L., Phillips, N. A., Xu, H., Ogurtsova, A., Berger, A. E., Pardoll, D. M., Topalian, S. L. & Ambinder, R. F., Jul 25 2017, In : Blood Advances. 1, 17, p. 1324-1334 11 p.

Research output: Contribution to journalArticle

Open Access

Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes

Hunter, N. B., Vogt, S. & Ambinder, R. F., Dec 15 2017, In : Oncology (Williston Park, N.Y.). 31, 12

Research output: Contribution to journalReview article

Unveiling Kaposi sarcoma viral antigens

Lee, J., Kosowicz, J. G. & Ambinder, R. F., Feb 7 2017, In : Oncotarget. 8, 31, p. 50325-50326 2 p.

Research output: Contribution to journalComment/debate

2016

Allogeneic stem cell transplantation

Ambinder, R. F., Kanakry, J. A. & Durand, C., Jan 1 2016, HIV-Associated Hematological Malignancies. Springer International Publishing, p. 165-171 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

A phase 1b/pharmacokinetic trial of PTC299, a novel posttranscriptional VEGF inhibitor, for AIDS-related Kaposi's Sarcoma: AIDS malignancy consortium trial 059

for the AIDS Malignancy Consortium (AMC)-059 Study Team, May 1 2016, In : Journal of acquired immune deficiency syndromes. 72, 1, p. 52-57 6 p.

Research output: Contribution to journalArticle

Autologous hematopoietic cell transplantation for HIV-related lymphoma: Results of the BMT CTN 0803/AMC 071 trial

Alvarnas, J. C., Le Rademacher, J., Wang, Y., Little, R. F., Akpek, G., Ayala, E., Devine, S., Baiocchi, R., Lozanski, G., Kaplan, L., Noy, A., Popat, U., Hsu, J., Morris, L. E., Thompson, J., Horowitz, M. M., Mendizabal, A., Levine, A., Krishnan, A., Forman, S. J. & 2 others, Navarro, W. H. & Ambinder, R., Aug 25 2016, In : Blood. 128, 8, p. 1050-1058 9 p.

Research output: Contribution to journalArticle

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

Ratner, L., Rauch, D., Abel, H., Caruso, B., Noy, A., Barta, S. K., Parekh, S., Ramos, J. C., Ambinder, R., Phillips, A., Harding, J., Baydoun, H. H., Cheng, X. & Jacobson, S., Mar 25 2016, In : Blood Cancer Journal. 6, p. e408

Research output: Contribution to journalLetter

EBV, an inhibited receptor kinase, and lymphoma

Ambinder, R. F., Sep 22 2016, In : Blood. 128, 12, p. 1542-1543 2 p.

Research output: Contribution to journalComment/debate

Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers

Li, L., Li, C., Mao, H., Du, Z., Chan, W. Y., Murray, P., Luo, B., Chan, A. T. C., Mok, T. S. K., Chan, F. K. L., Ambinder, R. F. & Tao, Q., May 26 2016, In : Scientific Reports. 6, 26591.

Research output: Contribution to journalArticle

Epstein-Barr Virus Infection

Kanakry, J. A. & Ambinder, R. F., Jan 1 2016, Thomas' Hematopoietic Cell Transplantation: Fifth Edition. Wiley Blackwell, Vol. 2-2. p. 1105-1113 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin Lymphoma

Jacene, H., Crandall, J., Kasamon, Y. L., Ambinder, R. F., Piantadosi, S., Serena, D., Kasecamp, W. & Wahl, R. L., Oct 31 2016, (Accepted/In press) In : Molecular Imaging and Biology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Outcomes in Transplant Recipients Treated with Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

Avery, R., Boger, R., Marr, K., Kraus, E., Shoham, S., Lees, L., Trollinger, B., Shah, P. D., Ambinder, R. F., Neofytos, D., Ostrander, D. B., Forman, M. & Valsamakis, A., Aug 5 2016, (Accepted/In press) In : Transplantation.

Research output: Contribution to journalArticle

Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium

Noy, A., Lensing, S. Y., Moore, P. C., Gupta, N., Aboulafia, D., Ambinder, R., Baiocchi, R., Dezube, B. J., Henry, D., Kaplan, L., Levine, A. M., Mitsuyasu, R., Ratner, L., Reid, E., Remick, S., Sparano, J., Tzachanis, D., Wachsman, W. & Chadburn, A., Jul 2 2016, In : Leukemia and Lymphoma. 57, 7, p. 1731-1734 4 p.

Research output: Contribution to journalLetter

Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)

Epeldegui, M., Lee, J. Y., Martínez, A. C., Widney, D. P., Magpantay, L. I., Regidor, D., Mitsuyasu, R., Sparano, J. A., Ambinder, R. F. & Martínez-Maza, O., Jan 15 2016, In : Clinical Cancer Research. 22, 2, p. 328-336 9 p.

Research output: Contribution to journalArticle

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

Lee, J. Y., Dhakal, I., Casper, C., Noy, A., Palefsky, J. M., Haigentz, M., Krown, S. E., Ambinder, R. F. & Mitsuyasu, R. T., 2016, In : Journal of Cancer Epidemiology. 2016, 2138259.

Research output: Contribution to journalArticle

The clinical significance of ebv DNA in the plasma and peripheral blood mononuclear cells of patients with or without ebv diseases

Kanakry, J. A., Hegde, A. M., Durand, C., Massie, A. B., Greer, A. E., Ambinder, R. F. & Valsamakis, A., Apr 21 2016, In : Blood. 127, 16, p. 2007-2017 11 p.

Research output: Contribution to journalArticle

Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre-and post-transplantation cyclophosphamide

Lombardi, L. R., Kanakry, C. G., Zahurak, M., Durakovic, N., Bolaños-Meade, J., Kasamon, Y. L., Gladstone, D. E., Matsui, W., Borrello, I., Huff, C. A., Swinnen, L. J., Brodsky, R. A., Ambinder, R. F., Fuchs, E. J., Rosner, G. L., Jones, R. J. & Luznik, L., Mar 3 2016, In : Leukemia and Lymphoma. 57, 3, p. 666-675 10 p.

Research output: Contribution to journalArticle

Tumor-infiltrating macrophages in post-transplant, relapsed classical Hodgkin lymphoma are donor-derived

Crane, G. M., Samols, M. A., Morsberger, L. A., Yonescu, R., Thiess, M. L., Batista, D., Ning, Y., Burns, K., Vuica-Ross, M., Borowitz, M. J., Gocke, C., Ambinder, R. F. & Duffield, A. S., Sep 1 2016, In : PLoS One. 11, 9, e0163559.

Research output: Contribution to journalArticle